6/28sat.16:30～呼吸器内科　医局説明会を開催します☆

最近の投稿

• 6/28sat.16:30～呼吸器内科　医局説明会を開催します☆
• 熊本呼吸器内科塾 2025
• Durvalumab With or Without Tremelimumab in Combination With Chemotherapy in First-Line Metastatic NSCLC: Five-Year Overall Survival Outcomes From the Phase 3 POSEIDON Trial
• 育成賞を受賞しました！
• Lorlatinib versus crizotinib in patients with advanced ALK-positive non-small cell lung cancer: 5-year outcomes from the phase III CROWN study